+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Collagenolytic matrix metalloproteinases antagonise proteinase-activated receptor-2 activation, providing insights into extracellular matrix turnover



Collagenolytic matrix metalloproteinases antagonise proteinase-activated receptor-2 activation, providing insights into extracellular matrix turnover



Journal of Biological Chemistry 2019



The collagenase subfamily of matrix metalloproteinases (MMP) have important roles in the remodelling of collagenous matrices. The proteinase-activated receptor (PAR) family have a unique mechanism of activation requiring proteolysis of an extracellular domain forming a neo-N terminus which acts as a tethered ligand, a process that has been associated with the development of arthritis. Canonical PAR2 activation typically occurs via a serine proteinase at Arg36-Ser37, but other proteinases can cleave PARs downstream of the tethered ligand and "disarm" the receptor. To identify additional cleavage sites within PAR2, we synthesised a 42-amino acid peptide corresponding to the extracellular region. We observed that all three soluble MMP collagenases - MMP-1, MMP-8, and MMP-13 - cleave PAR2 and discovered a novel cleavage site (Ser37-Leu38). Metalloproteinases from resorbing bovine nasal cartilage and recombinant human collagenases could cleave a quenched fluorescent peptide mimicking the canonical PAR2 activation region, and kinetic constants were determined. In PAR2-overexpressing SW1353 chondrocytes, we demonstrated that the activator peptide SLIGKV-NH2 induces rapid calcium flux, inflammatory gene expression (including MMP1 and MMP13), and the phosphorylation of extracellular signal-regulated kinase (ERK) and p38 kinase. The corresponding MMP cleavage-derived peptide (LIGKVD-NH2) exhibited no canonical activation, however we observed phosphorylation of ERK, providing evidence of biased agonism. Importantly, we demonstrated that pre-incubation with active MMP-1 reduced downstream PAR2 activation by a canonical activator, matriptase, but not SLIGKV-NH2 These results support a role for collagenases as proteinases capable of disarming PAR2, revealing a mechanism which suppresses PAR2-mediated inflammatory responses.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066803152

Download citation: RISBibTeXText

PMID: 31110047

DOI: 10.1074/jbc.ra119.006974


Related references

1,25-Dihydroxy vitamin D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60-activated matrix vesicle matrix metalloproteinases. Cells, Tissues, Organs 189(1-4): 70-74, 2008

1alpha,25(OH)2D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60 activated matrix vesicle metalloproteinases. Journal of Steroid Biochemistry and Molecular Biology 103(3-5): 467-472, 2007

Alpha,25OH2D-3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60 activated matrix vesicle metalloproteinases. Journal of Steroid Biochemistry and Molecular Biology 103(3-5, Sp. Iss. SI): 467-472, 2000

Leukemic cells produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases. Experimental Hematology (Charlottesville) 23(2): 155-160, 1995

Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs). Experimental Hematology 23(2): 155-160, 1995

Pancreatic stellate cells secrete matrix metalloproteinases Implications for extracellular matrix turnover. Pancreas 21(4): 470, November, 2000

Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover. Gut 52(2): 275-282, 2003

Regulation of matrix metalloproteinases during extracellular matrix turnover. Advances in Experimental Medicine and Biology 385: 151-9; Discussion 179-84, 1995

Involvement of matrix metalloproteinases and their inhibitors in endometrial extracellular matrix turnover in Chlamydia trachomatis-infected recurrent spontaneous aborters. Pathogens and Disease 75(1), 2017

Matrix metalloproteinases produced by IL-2 activated natural killer cells and extracellular matrix degradation. Natural Immunity 15(4): 187, 1996-, 1997

Mechanotransduction of extracellular signal-regulated kinases 1 and 2 mitogen-activated protein kinase activity in smooth muscle is dependent on the extracellular matrix and regulated by matrix metalloproteinases. American Journal of Pathology 169(2): 459-470, 2006

Relative importance of proteinase-activated receptor-1 versus matrix metalloproteinases in intracerebral hemorrhage-mediated neurotoxicity in mice. Stroke 40(6): 2199-2204, 2009

Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma. Clinical & Experimental Metastasis 20(7): 621-631, 2003

Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. Journal of Cell Biology 165(6): 893-902, 2004

Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Letters 157(2): 177-184, 2000